The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of 2 different doses of
canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are
receiving treatment with metformin and sulphonylurea and have inadequate glycemic (blood
sugar) control.